PGHH Announces Key Management Changes: New CFO Appointed, Directors Re-designated
PGHH announced changes in its leadership team. Ghanashyam Hegde ceases as Company Secretary on June 30, 2026, and becomes Non-Executive Director from July 1, 2026. Gaurav Bhartia resigns as CFO on June 30, 2026. Srividya Srinivasan appointed as new CFO and Executive Director from July 1, 2026.
Changes in key managerial personnel, particularly the CFO, can have a medium-term impact on the company's financial strategy and operations. The re-designation of a director also signifies a shift in governance structure.
The announcement details routine management changes and appointments, which are standard corporate actions and do not inherently suggest a positive or negative shift in the company's performance or outlook.
Procter & Gamble Hygiene and Health Care Limited (PGHH) announced significant changes in its leadership team during a Board meeting held on May 28, 2026.
Mr. Ghanashyam Hegde will cease to be the Company Secretary and Compliance Officer effective June 30, 2026, as he moves to a regional role within P&G. Subsequently, he has been re-designated as a Non-Executive Director of the Company, effective July 1, 2026. Mr. Hegde's new role will be Vice President & Associate General Counsel – Market Operations, India, Middle East, Turkey & Africa.
Mr. Gaurav Bhartia will also step down as the Chief Financial Officer on June 30, 2026, to take up a new assignment at P&G.
Ms. Srividya Srinivasan has been appointed as the new Executive Director and Chief Financial Officer, effective July 1, 2026. She will serve a term of five years, subject to Board approval at the upcoming 62nd Annual General Meeting. Ms. Srinivasan holds a Bachelor of Computer Science Engineering and an MBA in Finance. She brings over 20 years of experience in finance roles at P&G across various markets since joining in 2005. The company confirmed that Ms. Srinivasan is not debarred from holding a directorial office and is not related to any existing directors.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.